5. Pfizer (PFE)Forward yield: 4.2%
Pfizer is the world's largest drug maker, but shares have taken a beating this year due to the patent expiration of Lipitor, the company's top-selling cholesterol drug. Still, Pfizer has other drugs in the pipeline that will likely soften the blow, including Apixaban, an anti-coagulant that may be superior to existing treatments and addresses a $7 billion market.Earnings growth for Pfizer is projected to slow to only 3% a year, but the trade-off is a 4% dividend yield. In December, Pfizer increased its dividend by 10% to an $0.88 annual rate. The new dividend rate is payable March 6, 2012, to shareholders of record on Feb. 3, 2012. The company has paid dividends for 73 years and posted 29 consecutive years of increases, before cutting the dividend in 2009 to pay for the Wyeth acquisition. Risks to consider: A double-dip recession would hurt First PacTrust and GE. Pfizer may not be able to bring new drugs to market quickly enough to offset declining Lipitor sales. Action to take: My top pick within this group of stocks is GE, because of its impressive earnings and dividend growth, not to mention its solid position in so many industrial segments, including health care, infrastructure, technology, aviation and finances. I like Pfizer for its cash flow and yield, and RGC and Sysco for their consistent dividend-paying track records.
>>To see these stocks in action, visit the 5 Stocks With Growing Dividends to Buy Before Year-End portfolio on Stockpickr. Disclosure: Neither L. Springer nor StreetAuthority, LLC hold positions in any securities mentioned in this article. Also see:
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV